Correction: Crosstalk between abnormal TSHR signaling activation and PTEN/PI3K in the dedifferentiation of thyroid cancer cells
-
By
-
Fang Feng
-
Huiqin Han
-
Shuqi Wu
-
Hui Wang
-
July 17, 2026
Clinical Scorecard: Erratum: Interaction between Dysregulated TSHR Signaling and PTEN/PI3K Pathways in the Dedifferentiation of Thyroid Cancer Cells
At a Glance
| Category | Detail |
|---|
| Condition | Thyroid Cancer |
| Key Mechanisms | Dysregulated TSHR signaling and PTEN/PI3K pathways |
| Target Population | Patients with thyroid cancer |
| Care Setting | Oncology |
Key Highlights
- Correction of Figure 1 in the original article
- Abnormal TSHR signaling activation linked to thyroid cancer cell dedifferentiation
- Interaction between TSHR signaling and PTEN/PI3K pathways
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with thyroid cancer
Clinical Best Practices
Related Resources & Content
